| abstract |
A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I n n n n n n n n n n n n in which X is an oxygen atom or an ═N—OH group, n R is selected from the group consisting of n n n n n n n n n n n n n n n n A is a hydrogen atom or together with B a carbon-carbon bond, n B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, n C is a hydrogen atom or together with D a carbon-carbon bond, n D is a hydrogen atom or together with C a carbon-carbon bond, n E is a hydrogen atom or together with F a carbon-carbon bond, n F is a hydrogen atom or together with E a carbon-carbon bond, n or an addition salt with a pharmaceutically acceptable acid. |